SkyGem acquires 59.96% stake in Allergy Therapeutics, launches cash offer for remaining shares
LONDON, UK: SkyGem Acquisition Limited, a private company backed by ZQ Capital, has acquired 59.96% of the shares of Allergy Therapeutics for 1 pence per share. As a result of this acquisition, SkyGem is required to make a mandatory cash…